A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small ...
Please provide your email address to receive an email when new articles are posted on . ADP101 includes 15 substances from the nine most common food allergens. 56% of participants with multiple ...
Due to its increasing prevalence and psychological and physical effects in recent decades, food allergy (FA) has become a chronic condition in the United States (US). Recent research highlights that ...
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small ...
SAN DIEGO -- Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food allergy, largely because many patients couldn't tolerate OIT, ...
Please provide your email address to receive an email when new articles are posted on . 57% of patients with multi-food allergies and 46% of those with one food allergy reported anxiety. 8.7% of ...
Participants in the OUtMATCH trial are allergic to peanuts and at least two other foods among milk, eggs, wheat, cashews, walnuts and hazelnuts. A clinical trial has found that the medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results